Compared with vehicle-treated tumors, JapA reduced the expression levels of NFAT1 in both the MCF-7 and MDA-MB-231 breast cancer xenograft models, as detected by immunohistochemical staining (Figure 1D) and western blotting (Figure 1E). The gene discussed is NFATC2; the disease is breast cancer.